Signaturefd, LLC Rocket Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

$5.21 Billion
Q4 2024

A detailed history of Signaturefd, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 4,916 shares of RCKT stock, worth $53,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,916

Previous 1,171 319.81%

Holding current value

$53,092

Previous $21,000 190.48%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$11.35 - $18.82 $42,505 - $70,480	3,745 Added 319.81%	4,916 $61,000
Q3 2024 Oct 21, 2024	BUY	$17.6 - $25.88 $5,544 - $8,152	315 Added 36.8%	1,171 $21,000
Q2 2024 Jul 29, 2024	BUY	$20.66 - $26.72 $413 - $534	20 Added 2.39%	856 $18,000
Q1 2024 May 03, 2024	BUY	$26.16 - $30.74 $209 - $245	8 Added 0.97%	836 $22,000
Q4 2023 Jan 31, 2024	SELL	$16.78 - $31.94 $1,141 - $2,171	-68 Reduced 7.59%	828 $24,000
Q3 2023 Nov 03, 2023	BUY	$15.07 - $24.05 $5,982 - $9,547	397 Added 79.56%	896 $18,000
Q2 2023 Aug 01, 2023	BUY	$16.59 - $23.6 $1,360 - $1,935	82 Added 19.66%	499 $9,000
Q2 2022 Aug 10, 2022	BUY	$7.96 - $16.64 $1,217 - $2,545	153 Added 57.95%	417 $6,000
Q1 2022 May 02, 2022	BUY	$13.16 - $23.68 $3,184 - $5,730	242 Added 1100.0%	264 $4,000
Q4 2021 Jan 25, 2022	BUY	$21.52 - $36.02 $86 - $144	4 Added 22.22%	22 $0
Q3 2021 Oct 28, 2021	SELL	$27.42 - $48.97 $356 - $636	-13 Reduced 41.94%	18 $1,000
Q2 2021 Jul 26, 2021	BUY	$39.41 - $47.25 $1,221 - $1,464	31 New	31 $1,000
Q1 2021 Apr 30, 2021	SELL	$43.34 - $65.91 $1,386 - $2,109	-32 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$23.3 - $59.57 $745 - $1,906	32 New	32 $2,000
Q2 2020 Jul 30, 2020	SELL	$13.32 - $22.61 $745 - $1,266	-56 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$11.07 - $24.23 $619 - $1,356	56 New	56 $1,000

Others Institutions Holding RCKT

# of Institutions

244

Shares Held

108M

Call Options Held

262K

Put Options Held

159K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $817M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account